Rituximab in combination with glucocorticoids for treating anti-neutrophil cytoplasmic antibody-associated vasculitis

Technology appraisal guidance
Reference number: TA308
Published: 26 March 2014

Evidence

Supporting evidence

Review decision
Review decision – May 2017
Review decision paper – May 2017 (PDF 142 KB)

Published:

26 May 2017